An experimental obesity pill mimics gastric bypass surgery // Wired
Syntis Bio, a biopharmaceutical company co-founded by Institute Professor Robert Langer and Associate Professor Giovanni Traverso, is developing a daily obesity pill that mimics the effects of gastric bypass, without requiring surgery. “This material is something you would take as a capsule or liquid, but the next day it’s gone because of the natural turnover of our mucosal surface in the GI tract,” says Traverso.
|